A SPIKING FEVER
Long neglected, LASSA FEVER is surging in West Africa. Researchers want to know why
In September 2023, 13-year-old Ngozu Ofozor was preparing to go home after spending 2 weeks in the Lassa Fever Isolation Ward science.org/content/articl…
2) Lassa fever has long been concentrated in endemic areas in Nigeria, Guinea ... But in recent years, cases of the deadly hemorrhagic disease have been popping up in other parts of West Africa. With climate change and population growth, the virus is expected to extend its reach
3) Scientists isolated the virus from 14 specimens of multimammate mouse, Mastomys natalensis, so-called because of its long rows of nipples for nursing big litters. science.org/doi/10.1126/sc…
4) Since 2016, several other rodent species in Nigeria, Guinea, Ghana, and Benin have been shown to harbor the virus. But M. natalensis remains the main driver of deadly outbreaks pubmed.ncbi.nlm.nih.gov/27140942/
5) Survivors’ stories
Many of those who recover from Lassa fever have dealt with life-changing consequences. Some are shunned by their communities, and many have permanent hearing loss. Health care workers face a particularly high risk of infection.
6) With a large team of African, European, and U.S. researchers, Sabeti and Happi analyzed blood samples collected earlier from Lassa fever patients at ISTH and KGH and sequenced 183 viral genomes, as well as 11 more from M. natalensis field samples. nature.com/articles/s4156…
7) Now, 17 years after Sabeti’s initial observation, she, Happi, and colleagues, in their new study, published this month in Nature Microbiology shed light on the long-standing mystery of why some people develop severe disease and some mild nature.com/articles/s4146…
8) Most attention has focused on ecological factors that favor virus circulation, perhaps by influencing its survival outside the host, or rodent behavior. Rainfall and to a lesser extent temperature seem to be key.
9) By 2070, under a “moderate” climate change scenario, areas suitable for Lassa virus circulation could cover most of the region between Guinea and Nigeria. Susceptible regions could also appear for the first time in parts of Central and East Africa.
10) CONCLUSION
No one expects the Lassa virus to spark a global pandemic—unlike respiratory viruses such as SARS-CoV-2 that easily spread from one person to another. But for those who study the disease and treat its victims, the steady march of the disease is alarming
"70% to 90% of our CELLS are completely RENEWED in less than 5 YEARS!
So If we’re mostly "New", why are so many still struggling with SARS-CoV-2?
We will tackle this question, which is more complex than it seems, in several posts.
2) First, let's say a few words about cell renewal.
70% to 90% of our cells are renewed over time. This turnover occurs in various cell types, including skin, blood, and immune cells, allowing the body to replace damaged or aged cells. sciencefocus.com/the-human-body…
3) For instance, red blood cells have a lifespan of about 120 days, while skin cells regenerate every few weeks.
Even with significant cell renewal, aging persists due to changes in our DNA. sciencefocus.com/the-human-body…
2) Co-infection occurs when a person is infected by more than one virus at the same time. This can lead to interesting and sometimes complex interactions between the viruses
3) In one study about SARS-CoV-2, researchers found that when different versions of this virus infect the same person, they can mix their genetic material through a process called recombination. This means that the new version of the virus can have traits from both parent viruses
For more than three years, we have been emphasizing that the envelope protein is an essential component and that we cannot limit our focus to just the spike protein. We are now uncovering its role in long COVID.
3) The Envelope (E) protein of SARS-CoV-2 plays a crucial role for several reasons:
▶️ Virus Assembly and Release: The E protein is essential for the virus's assembly and budding from infected cells, contributing to its stability and infectivity.
In 2022, COVID-19 was the second leading cause of death globally, with the repercussions of the virus far from over. The lasting impact of the pandemic continues to affect lives around the world.
Recent research may have identified a key factor contributing to long COVID: microscopic clots intertwined with immune system debris in the blood. These unusual structures were found to be nearly 20 times more prevalent ...
2) ...in long COVID patients compared to healthy individuals. The clots, associated with neutrophil extracellular traps (NETs), suggest a potential biological marker for persistent symptoms.
3) These microclots could impede blood flow in small vessels, leading to issues like brain fog, fatigue, and shortness of breath.
Unlocking the Secrets: A Comprehensive Megathread on Key Virus Subtypes of Human and Avian Influenza !"🧵
First, a quick overview of the different subtypes:
HUMAN INFLUENZA
H1N1 : The 2009 pandemic strain, which continues to circulate
...
2) H3N2: Strain spreading fast actually and causing significant morbidity
H6N1: Notable for potential human impact.
AVIAN INFLUENZA :
H5N1: High pathogenicity, zoonotic concerns.
H3N8: Emerging strain of interest.
H7N9: Associated with human infections, sporadic outbreaks.
3) H5N8: Emerging strain with health implications.
H5N6: Recent cases in birds and humans.
H7N7: Impact on poultry and occasional human cases.
H9N2: Common in birds, history of human infections.